Pure Global AI
NCT06298773Not yet recruiting

Spatial Profile of Tumors

SPATIAL PROFILE OF SUBPOPULATIONS OF CANCER AND IMMUNITARY CELLS IN SEVERAL SOLID TUMORS
Fondazione Policlinico Universitario Agostino Gemelli IRCCSClinicalTrials.govother
Verified
Study focus
Disease/Condition
Solid Tumors
Drug/Device/Intervention
Spatial analysis of paraffin samples from solid tumors
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Location
Rome, Italy
Timeline & enrollment
Phase
N/A
Start date
Mar 05, 2024
End date
Dec 30, 2028
Enrollment
1000 participants
Primary outcome

Spatial analysis of cancer cells

Summary

The research project focuses on analyzing the spatial organization of cells within various
 solid tumors, utilizing advanced technologies enabling in-depth multi-parametric analysis of
 tumor and immune cells. The primary objective is to understand the spatial distribution of
 cellular subpopulations within each type of tumor, while secondary objectives include
 correlating these data with clinical aspects and identifying potential therapeutic targets.
 The study involves 1000 patients with primary or metastatic tumors and spans a duration of 5
 years, from 2024 to 2028. No experimental treatments are planned; rather, only spatial
 imaging analyses with multiple markers will be conducted. Data analysis involves descriptive
 statistical methods and hypothesis testing to generate hypotheses for subsequent studies. The
 analyses will be performed using SPSS® version 21.0 software for Windows®.

ICD-10 classifications
Malignant neoplasm: Connective and soft tissue, unspecifiedMalignant neoplasm of other connective and soft tissueCarcinoma in situ, unspecifiedMalignant neoplasmsMalignant neoplasm: Parametrium
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06298773
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06298773 through Pure Global AI's free database. This phase not specified trial is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS and is currently Not yet recruiting. The study focuses on Solid Tumors. Target enrollment is 1000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.